Next Article in Journal
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer
Next Article in Special Issue
Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
Previous Article in Journal
Neurotransmitters: Potential Targets in Glioblastoma
Previous Article in Special Issue
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(16), 3971; https://doi.org/10.3390/cancers14163971
Action Date Notes Link
article xml file uploaded 17 August 2022 11:46 CEST Original file -
article xml uploaded. 17 August 2022 11:46 CEST Update https://www.mdpi.com/2072-6694/14/16/3971/xml
article pdf uploaded. 17 August 2022 11:46 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/3971/pdf
article html file updated 17 August 2022 11:47 CEST Original file https://www.mdpi.com/2072-6694/14/16/3971/html
Back to TopTop